Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis

The S100B protein is associated with brain damage and a breached blood–brain barrier. A previous pilot study showed that high serum levels of S100B are associated with shorter survival in glioma patients. The aim of our study was to assess the prognostic value in terms of survival and longitudinal d...

Descripción completa

Detalles Bibliográficos
Autores principales: Holla, F. K., Postma, T. J., Blankenstein, M. A., van Mierlo, T. J. M., Vos, M. J., Sizoo, E. M., de Groot, M., Uitdehaag, B. M. J., Buter, J., Klein, M., Reijneveld, J. C., Heimans, J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020117/
https://www.ncbi.nlm.nih.gov/pubmed/27401156
http://dx.doi.org/10.1007/s11060-016-2204-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020117/
https://www.ncbi.nlm.nih.gov/pubmed/27401156
http://dx.doi.org/10.1007/s11060-016-2204-z

Ejemplares similares